Department of Neurology, Faculty of Medicine, University of Rijeka, 51000 Rijeka, Croatia.
Department of Neurology, Clinical Hospital Center Rijeka, 51000 Rijeka, Croatia.
Genes (Basel). 2024 Feb 19;15(2):255. doi: 10.3390/genes15020255.
Parkinson's disease is a neurological disorder that affects motor function, autonomic functions, and cognitive abilities. It is likely that both genetic and environmental factors, along with age, contribute to the cause. However, there is no comprehensive guideline for genetic testing for Parkinson's disease, and more research is needed to understand genetic variations in different populations. There has been no research on the genetic background of Parkinson's disease in Croatia so far. Therefore, with the GiOPARK project, we aimed to investigate the genetic variants responsible for Parkinson's disease in 153 Croatian patients with early onset, familial onset, and sporadic late-onset using whole-exome sequencing, along with multiplex ligation-dependent probe amplification and Sanger sequencing in select patients. We found causative variants in 7.84% of the patients, with GBA being the most common gene (4.58%), followed by PRKN (1.96%), ITM2B (0.65%), and MAPT (0.65%). Moreover, variants of uncertain significance were identified in 26.14% of the patients. The causative variants were found in all three subgroups, indicating that genetic factors play a role in all the analyzed Parkinson's disease subtypes. This study emphasizes the need for more inclusive research and improved guidelines to better understand the genetic basis of Parkinson's disease and facilitate more effective clinical management.
帕金森病是一种影响运动功能、自主功能和认知能力的神经退行性疾病。遗传和环境因素以及年龄都可能导致帕金森病的发生。然而,目前尚无针对帕金森病的全面基因检测指南,需要进一步研究以了解不同人群中的遗传变异。到目前为止,克罗地亚尚未对帕金森病的遗传背景进行研究。因此,我们通过 GiOPARK 项目,旨在使用外显子组测序,以及在选择的患者中进行多重连接依赖性探针扩增和 Sanger 测序,研究 153 名克罗地亚早发性、家族性和散发性晚发性帕金森病患者中导致帕金森病的遗传变异。我们在 7.84%的患者中发现了致病变异,最常见的基因是 GBA(4.58%),其次是 PRKN(1.96%)、ITM2B(0.65%)和 MAPT(0.65%)。此外,26.14%的患者存在意义不明的变异。致病变异存在于所有三个亚组中,表明遗传因素在所有分析的帕金森病亚型中都起作用。本研究强调需要进行更具包容性的研究和制定更好的指南,以更好地了解帕金森病的遗传基础,并促进更有效的临床管理。